Janux Therapeutics’ $350 Million Common Stock Offering

Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here